Hybridan Small Cap Feast: 30 March 2026
The international developer, manufacturer and regulatory services provider for rapid diagnostic tests and medtech is awarded a series of contracts...
132 Views
No more insights
𝛼SK or SearchENTITY
Bioventix (BVXP LN)
Bioventix (BVXP LN)
5
Analysis
Health Care • United Kingdom
Bioventix specializes in the development and commercial supply of high-affinity sheep monoclonal antibodies (SMAs) for use in immunodiagnostics, particularly in clinical diagnostics and drugs of abuse testing. These antibodies are beneficial for detecting targets present at low concentrations or small molecules. The company is headquartered in Farnham, Surrey, UK, and was founded in 2003.
morex